Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
7.60
-0.04 (-0.52%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Addex Therapeutics Employees
Addex Therapeutics had 23 employees as of December 31, 2023. The number of employees decreased by 1 or -4.17% compared to the previous year.
Employees
23
Change (1Y)
-1
Growth (1Y)
-4.17%
Revenue / Employee
$30,490
Profits / Employee
$278,186
Market Cap
6.34M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
ADXN News
- 7 days ago - Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149 - GlobeNewsWire
- 3 months ago - Addex to Present at the 2025 Swiss Equities Baader Conference - GlobeNewsWire
- 5 months ago - Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024 - GlobeNewsWire
- 7 months ago - Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit - GlobeNewsWire